Emerging evidence even suggests these medications may positively influence energy expenditure and overall metabolic health, although research in this area is still ongoing
Zhu H, Zhou L, Wang Q, Cai Q, Yang F, Jin H et al (2023) Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort
FAQs If we havent answered all of your questions, feel free to contact us
It may increase glucose uptake by breaking down TAGs in chylomicrons through LPL activity and transporting glucose through a protein called GLUT4
They can review factors such as your personal and family health history, current weight, and health conditions to determine if GLP-1 therapy is suitable for you
Limiting inflammation-the negative regulation of NF-kappaB and the NLRP3 inflammasome